Literature DB >> 7105417

A reproducible sodium-lithium countertransport assay: the outcome of changing key laboratory parameters.

J B Smith, A L Price, R R Williams, W M Hentschel, W Sprowell, S C Hunt, K O Ash.   

Abstract

This paper describes experimental conditions for reproducible measurement of sodium-lithium countertransport in red blood cells. The assay is sensitive to temperature (10% per degree C) and the condition of the red cells; it is affected little by changes in intracellular lithium over the range 2-7 mmol/1 or by red cell concentrations with laboratory hematocrits of 0.03 to 0.07. Repeated measurements of the same subjects give day-to-day coefficients of variation of 10% or less. The mean difference for interlaboratory comparisons is 11%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105417     DOI: 10.1016/0009-8981(82)90135-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.

Authors:  S C Hunt; R R Williams; K O Ash
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

2.  Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10.

Authors:  Alanna C Morrison; Eric Boerwinkle; Stephen T Turner; Robert E Ferrell
Journal:  Am J Hypertens       Date:  2008-01       Impact factor: 2.689

3.  Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance.

Authors:  S J Hasstedt; L L Wu; K O Ash; H Kuida; R R Williams
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

4.  Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes.

Authors:  T C Hardman; S W Dubrey; D G Leslie; M Hafiz; M I Noble; A F Lant
Journal:  BMJ       Date:  1992-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.